Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05292> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05292 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05292 label "IDM-1 [drugbank:DB05292]" assertion.
- drugbank:DB05292 seeAlso DB05292 assertion.
- drugbank:DB05292 description "IDM-1 is IDMâs most advanced antibody-based Cell drug for the treatment of cancer. It is comprised of MAK(Monocytes-derived Activated Killer) cells associated with MDX-210, a bispecific anti-HER-2/neu antibody developed by Medarex Inc." assertion.
- drugbank:DB05292 identifier "drugbank:DB05292" assertion.
- drugbank:DB05292 title "IDM-1" assertion.
- drugbank:DB05292 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05292 drugbank_vocabulary:drugbank-id "DB05292" assertion.
- drugbank:DB05292 bio2rdf_vocabulary:x-identifiers.org DB05292 assertion.
- drugbank:DB05292 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05292" assertion.
- drugbank:DB05292 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05292 bio2rdf_vocabulary:identifier "DB05292" assertion.